| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |